Single-stranded RNA (ssRNA) is used across molecular biology as an antisense reagent, aptamer, ribozyme, probe, enzyme substrate, hybridization partner, and defined RNA standard. The appropriate synthesis route depends strongly on sequence length, modification pattern, quantity, and downstream assay. Short and medium-length ssRNA oligonucleotides are often best prepared by solid-phase RNA chemistry, while longer constructs may be more practical by in vitro transcription or fragment-ligation approaches.
Our custom ssRNA synthesis service integrates sequence review, route selection, chemical modification, labeling, purification, and analytical verification. Projects can connect with custom RNA oligonucleotide synthesis, long RNA oligo synthesis, or long RNA transcription depending on the required length and chemistry.
RNase Sensitivity: RNA is vulnerable to ubiquitous RNases, so handling, purification, formulation, and downstream storage require RNase-aware workflows and clean materials.
Length-Dependent Yield: Stepwise chemical synthesis becomes more demanding as RNA length increases because incomplete coupling and deprotection create a growing population of truncated products. Longer constructs may require enzymatic transcription or segment assembly.
2′-OH Chemistry: The ribose 2′-hydroxyl group increases the complexity of protecting-group strategy and deprotection relative to DNA synthesis. Modification compatibility must be reviewed across the entire sequence.
Secondary Structure: GC-rich regions, repeats, and stable intramolecular structures can affect synthesis workup, purification, quantification, hybridization, and functional use.
Modification and Label Effects: Fluorophores, lipids, amino/thiol groups, backbone changes, or modified nucleosides can alter charge, hydrophobicity, folding, and purification behavior.
Purification Resolution: Short failure products, n−1 species, double-stranded contaminants, abortive transcripts, or ligation intermediates may require different purification modes depending on the production route.
We select the production route from the requested RNA rather than forcing all sequences through one process. Sequence length, site-specific chemistry, terminal requirements, quantity, and the need for homogeneous ends are evaluated together.
For projects requiring extensive modification, our ssRNA workflow can be coordinated with DNA/RNA modification and oligo analysis and purification to keep synthesis chemistry and downstream verification aligned.
The most useful production route depends on the required length, chemical diversity, end definition, and amount of RNA rather than a single cutoff value.
| Production Route | Best Fit | Modification Flexibility | Primary Strength | Main Constraint |
| Solid-Phase Chemical Synthesis | Short to medium-length ssRNA with defined sequence and site-specific chemistry | High for compatible synthetic modifications | Precise sequence, terminal chemistry, labels, and position-specific changes | Crude complexity and yield challenges increase with length |
| In Vitro Transcription | Longer ssRNA where enzymatic production is compatible with the sequence | Moderate; depends on polymerase/substrate tolerance | Efficient generation of longer RNA from a DNA template | 5′/3′ end heterogeneity and template/abortive transcript removal may require optimization |
| Fragment Ligation | Long RNA requiring one or more site-specific synthetic modifications | High at chemically synthesized segments | Combines long-RNA assembly with local chemical control | Ligation junction design and purification add complexity |
| Hybrid Chemical + Enzymatic | Complex RNA where different regions have different chemistry needs | High and project-specific | Flexible route for difficult modified constructs | Requires multistep production, intermediate QC, and final assembly |
Purification and analysis should reflect the route used to make the RNA and the types of impurities expected from that route.
| Method | Primary Purpose | Best Fit | Useful Output | Key Consideration |
| Desalting / SPE | Remove salts and small-molecule reagents | Routine chemical-synthesis cleanup or buffer exchange | Cleaned RNA preparation | Does not remove closely related truncated sequences |
| RP-HPLC | Separate by hydrophobicity/ion-pair interaction | Short/medium ssRNA and many labeled or hydrophobic modified RNAs | Purified fractions and analytical chromatogram | Mobile phase and label chemistry influence retention |
| Ion-Exchange HPLC | Separate by charge/length | Longer or highly charged ssRNA | Charge-based purification and chromatographic profile | Requires optimized salt gradient and pH |
| Denaturing PAGE | Resolve full-length from shorter RNA products | Long oligos, difficult truncation profiles, selected IVT/ligation products | Isolated target band and integrity check | Recovery and post-extraction cleanup must be considered |
| Mass Spectrometry | Confirm expected molecular mass | Chemically synthesized ssRNA and compatible modified RNAs | Observed vs. expected mass | Large RNAs and some heterogeneous products may need alternative characterization |
| CE / Gel Analysis | Assess size and integrity | Longer ssRNA, IVT products, degradation checks | Electrophoretic size distribution | Structure and modification can affect mobility |
A route-selection step at the beginning prevents length, modification, or purification requirements from being discovered only after synthesis has started.
Collect RNA sequence, length, desired quantity, terminal groups, internal modifications, labels, purity target, buffer preference, and intended research application.
Evaluate whether solid-phase synthesis, IVT, fragment ligation, or a hybrid route provides the best balance of positional chemistry, length capability, and expected recovery.
Finalize protecting-group strategy, modified monomers, template/promoter design, ligation junctions, and anticipated purification method.
Execute chemical synthesis, transcription, segment preparation, or multistep assembly with in-process checks appropriate to the selected route.
Remove truncated products, templates, abortive RNA, salts, or reaction components using a method matched to the expected impurity profile.
Complete mass, chromatographic, electrophoretic, concentration, or other agreed checks and deliver the ssRNA in the requested research-use format.
ssRNA projects vary widely in length and chemistry. A route-matched approach helps preserve sequence control while avoiding unnecessary constraints from any single synthesis platform.
Single-stranded RNA can serve as a sequence-specific reagent, folded functional RNA, probe, substrate, or building block for more complex nucleic acid systems.
Send the ssRNA sequence, required quantity, desired modifications or labels, preferred purification level, and downstream application. We will recommend a production route based on length and chemistry and define the corresponding purification and analytical package. Related capabilities include custom RNA oligonucleotide synthesis, long RNA oligo synthesis, RNA modification, and oligo analysis and purification. Contact us to discuss your ssRNA project.
Solid-phase chemical synthesis is well suited to short and medium-length RNAs with site-specific modifications. Longer RNAs may be better produced by in vitro transcription, while fragment ligation can combine long length with local chemical modification.
Depending on sequence and route, options can include modified bases, 2' ribose chemistry, backbone changes, terminal groups, spacers, amino or thiol functions, and fluorescent or affinity labels.
Purification may use HPLC, ion-exchange chromatography, denaturing PAGE, desalting, or a combination of methods. The choice depends on RNA length, synthesis route, modification pattern, and expected impurities.
In some cases, a hybrid route can be used in which a chemically modified RNA segment is ligated to longer enzymatically produced RNA. Feasibility depends on modification position, ligation junctions, and final purification.
RNA should be handled with RNase-aware technique using clean consumables and appropriate nuclease-free buffers. Storage concentration, freeze-thaw exposure, and refolding conditions should be matched to the sequence and downstream assay.
Loading ......
